Your browser doesn't support javascript.
loading
Effects of ilaprazole on the steady-state pharmacodynamics of clopidogrel in healthy volunteers: An open-label randomized crossover study.
Ye, Zekang; Chen, Pengsheng; Tan, Chuchu; Gong, Xiaoxuan; Li, Ran; Dong, Zhou; Ullah, Inam; Zhou, Chen; Zhou, Sufeng; Xie, Lijun; Hou, Xuemei; Han, Zhihui; Gu, Qian; Ma, Jiazheng; Teng, Jianzhen; Tang, Yingdan; Zhang, Zhuanxia; Hu, Haitang; Zhuang, Quankun; Chen, Juan; Zhu, Bei; Shao, Feng; Li, Chunjian.
Afiliación
  • Ye Z; Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Chen P; Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Tan C; Department of Cardiology, Xuzhou Central Hospital, Xuzhou, Jiangsu, China.
  • Gong X; Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Li R; Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Dong Z; Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Ullah I; Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Zhou C; Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Zhou S; Phase I Clinical Trial Unit, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Xie L; Phase I Clinical Trial Unit, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Hou X; Phase I Clinical Trial Unit, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Han Z; Lizhu Medical Research Institute, Lizhu Group, Zhuhai, Guangdong, China.
  • Gu Q; Lizhu Medical Research Institute, Lizhu Group, Zhuhai, Guangdong, China.
  • Ma J; Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Teng J; Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Tang Y; Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Zhang Z; Department of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Hu H; Lizhu Medical Research Institute, Lizhu Group, Zhuhai, Guangdong, China.
  • Zhuang Q; Lizhu Medical Research Institute, Lizhu Group, Zhuhai, Guangdong, China.
  • Chen J; Phase I Clinical Trial Unit, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Zhu B; Phase I Clinical Trial Unit, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Shao F; Phase I Clinical Trial Unit, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Li C; Phase I Clinical Trial Unit, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Front Pharmacol ; 13: 952804, 2022.
Article en En | MEDLINE | ID: mdl-36160382
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza